FierceBiotech ٩ يناير ٢٠٢٦ Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential المصدر